Jason Liu, MD
In the early 2000s, Dr. Liu began his business in the field of biotechnology. He worked and cooperated with a group of experts and scientists in the fields of molecular biology, stem cells, genomics, proteins, and enzymology. Dr. Liu was also involved in the international trade of medical equipment and instruments.
In 2010, he established Amerita Labs, Inc. with his business partner, Mr. Gan Jin. Dr. Liu and his partner have worked with specialists, experts, federal government officers, lawyers, and FDA professionals in the fields of biotechnology and biopharmaceuticals. With tremendous efforts, they extended their biotechnology business globally. The company soon conducted business with many professionals in the USA, as well as China.
In addition to being the president of Amerita Labs, Inc, Dr. Liu is also a business partner of the California-Jiangsu Enterprise Development Group (CJEDG). CJEDG specializes in forging strategic partnerships with the industries of aerospace, advanced agriculture, bio-medicine, business and executive management, environmental protection, executive education, innovation and entrepreneurship, information technology, maritime and ocean science, new energy solutions, and new material productions.
Dr. Jason Liu graduated from Hunan Medical University, Changsha, Hunan, China. He immigrated to the United States in the 1980s. In 1987, Dr. Liu was the clinical investigator and leader of the NIH granted project in the Department of Urology at the University of Michigan, School of Medicine. Dr. Liu completed his post-doctoral training at the Johns Hopkins University School of Medicine, where he served as the primary clinical investigator in the Brady Urological Institute.
Dr. Liu later on switched his career to the IT field, completing his Masters degree in computer science at Towson University. He worked as the Oracle Principal Consultant, and was responsible for the federal government database management of the General Service Administration, Substance Abuse and Mental Health Services Administration, and the United States Coast Guard.
Currently, Dr. Liu’s focus is in the field of biopharmaceuticals. As the president of Amerita Labs, Inc., he is dedicated to the discovery of new innovations in biotechnology and medicine that will ultimately bring China’s biopharmaceutical business to the world class level.